• Product NameEBV Nuclear Antigen Antibody HRP Conjugated
• Host SpeciesRabbit
• ClonalityPolyclonal
• IsotypeIgG
• PurificationPurified by Protein A.
• ApplicationsWB IHC-P IHC-F
• Species ReactivityEBV
• Crossing ReactivityEpstein Barr Virus
• Immunogen DescriptionKLH conjugated synthetic peptide aa 550-600 641 derived from EBV Nuclear Antigen
• ConjugatesHRP
• Excitation EmissionN A
• Target NameEBV Nuclear Antigen
• Alternative Names    EBNA1; EBNA-1; EBV nuclear antigen 1; Epstein Barr nuclear antigen 1; Epstein Barr virus; BKRF1; Epstein-Barr nuclear antigen 1; EBV nuclear antigen 1;
• Cell Localization Nucleus
• Concentration 1mg ml
• Formulation 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
• Storage Shipped at 4˚C. Store at -20˚C for one year. Avoid repeated freeze/thaw cycles.

• WB=1:500-2000 IHC-P=1:50-200 IHC-F=1:50-200

Epstein-Barr virus (EBV) nuclear antigen 1 (EBNA1) is the one EBV antigen that is expressed in all EBV associated malignancies. It has long been thought to go undetected by the cell mediated immune system. However, recent studies show that EBNA1 can be presented to both CD4+ and CD8+ T cells, making it a potential new target for immunotherapy of EBV related cancers.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting